Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

VirtualScopics Schedules Third Quarter 2010 Earnings Announcement

October 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., Oct. 21 /- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that before the market opens on Thursday, November 11, 2010 it will release its third quarter 2010 financial results. The company will host a...

Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics

October 21, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

RICHMOND, Calif., Oct. 21 /- Lumiphore Inc., a biotechnology leader in new proprietary bifunctional metal-chelation technology for use in high-value imaging, diagnostics, and therapeutics and Algeta ASA (OSE:ALGETA), the cancer therapeutics company, announced that they have signed a...

IDEV Technologies Launches Additional Products in Europe

October 21, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

WEBSTER, Texas, Oct. 21 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients...

Advertisement

Danaher Reports Record Third Quarter 2010 Results

October 21, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 21 /- Danaher Corporation (NYSE: DHR ) announced today that GAAP net earnings for the quarter ended October 1, 2010 were $646.4 million, or $0.95 per diluted share, which includes a $0.34 gain related to the formation of the Apex Tool Group joint venture, and represents a...

Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor

October 21, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

LONDON, Oct. 21 /- Shionogi-ViiV Healthcare LLC today announced the start of the Phase III clinical programme evaluating its once-daily, unboosted investigational integrase inhibitor, S/GSK1349572 ('572). The Phase III clinical programme, which began this month, includes two studies...

Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C

October 21, 2010 1:31 am | by Bio-Medicine.Org | News | Comments

VIENNA, Oct. 21 /- Intercell AG (VSE; "ICLL") and Romark Laboratories L.C. today announced plans to commence clinical trials of Intercell's investigational therapeutic Hepatitis C virus (HCV) vaccine, IC41, in combination with Romark's antiviral drug, nitazoxanide, during the first half...

Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis)

October 20, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to... -- MUMBAI, India, October 20, 2010 /-

Genoptix Ranked 41st Fastest-Growing Company in North America on Deloitte's 2010 Technology Fast 500™

October 20, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Oct. 20 /- Genoptix, Inc. (Nasdaq: GXDX ), a specialized laboratory services provider, today announced that it ranked number 41 on Technology Fast 500™, Deloitte's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean...

Advertisement

Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010

October 20, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., Oct. 20 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2010, income from continuing operations increased to $198 million, or $1.13 per...

Uroplasty to Issue Second Quarter 2011 Results on October 27, 2010

October 20, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Oct. 20 /- Uroplasty, Inc. (Nasdaq: UPI ) announced today that it will release financial results for the second quarter ended September 30, 2010, at the market close on Wednesday, October 27, 2010.  The Company will host a conference call to discuss these results on...

BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors

October 19, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

SEOUL, South Korea, Oct. 19 /- BioMolecular Therapeutics, Inc. (BMT, Inc.), a new Seoul-based RNAi therapeutics company with a proprietary technology designed to reduce significantly deleterious side effects triggered by conventional siRNA, announced that it has launched its global...

LifePort Inc. Signs Two Agreements Launching Company Into Mission-Specific Seating

October 19, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Oct. 19 /- NBAA Trade Show -- LifePort Inc. today announced the signing of two agreements that launch the company into customized mission-specific seating. LifePort is a Sikorsky Aerospace Services (SAS) company – the aftermarket division of Sikorsky Aircraft Corp., a...

Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium

October 19, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

COLUMBIA, Md., Oct. 19 /- Celsion Corporation (Nasdaq: CLSN ) announced today that two abstracts on the ThermoDox® High Intensity Focused Ultrasound (HIFU) development program have been delivered via oral presentation at the MR-guided Focused Ultrasound 2010 2nd International...

Advertisement

Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research

October 19, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Oct. 19 /- Ingenuity® Systems, the leading provider of information solutions for life science researchers, and TransMed Systems, a translational medicine software and services company, today announced an integration between IPA® software and XB...

Reportlinker Adds Global Urological Catheters Industry

October 18, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 18 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Urological Catheters Industry http://www.reportlinker.com/p087354/Global-Urological-Catheters-Industry.html This report analyzes the worldwide markets for Urological...

Top U.S. and Korean Companies to Converge at 2010 Global Partnering Day

October 18, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 18 /- The epicenter of the technology world moves to Basking Ridge, NJ when " 2010 Global Partnering Day ," sponsored by the Korean Trade-Investment Promotion Agency (KOTRA), kicks off later this month. The conference is free for businesses to attend, and it brings together...

Hospital Council of Western Pennsylvania Announces Foundation Radiology Group as Newest Partner

October 18, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 18 /- Foundation Radiology Group (FRG), the region's premier provider of diagnostic imaging services, is pleased to announce that it has been named the Hospital Council of Western Pennsylvania's newest business partner. FRG is a Pittsburgh-based radiology practice that...

Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement

October 18, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

PLANTATION, Fla., Oct. 18 /- Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin...

Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success

October 18, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 18 /- Innovation is the key to success for medical device companies in today's economy. However, not only must companies produce superior products, but they must also effectively manage each product's entire lifecycle to achieve success. This includes...

Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan

October 18, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

PARIS and KYOTO, Japan, Oct. 18 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent...

Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum

October 17, 2010 8:33 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the...

Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date

October 17, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Oct. 15 /- Generex Biotechnology Corporation (Nasdaq: GNBT, www.generex.com ) today announced that it reconvened a special meeting of stockholders (the "Special Meeting") on October 15, 2010 at 10:00 a.m. (local time) at the Meeting Rooms, Westin Harbour Castle Hotel, 1...

New Online Pharmacy RxBuys.com is Launched by One of the Leading Pharmaceutical Companies, Rx Corp

October 17, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Oct. 17 /- The new online pharmacy was launched after the company had studied the market of pharmaceuticals, coming to the conclusion there are not enough reliable and trustworthy places to shop for high quality prescription medications. With the many years of experience...

ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™

October 16, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Oct. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye...

Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches ...

October 16, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- AdvaMed 2010 : The MedTech Conference opens on Monday, October 18 with a series of free educational Executive Workshops focused on bringing products to the US markets, a 1/2 day entrepreneur bootcamp, and minimizing risk and global...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading